PTC Therapeutics | PTCT - Kapitalizacja Rynkowa





Kapitalizacja Rynkowa Zmiana Data
Acadia Pharmaceuticals USD 4.33B 537M 2026-06
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
Amgen USD 195.44B 5.55B 2026-06
BioCryst Pharmaceuticals USD 2.54B 880M 2026-06
Biogen USD 31.9B 5B 2026-06
BioMarin Pharmaceutical USD 11.06B 196M 2026-06
Cytokinetics USD 11.55B 3.36B 2026-06
Enanta Pharmaceuticals USD 122M 98M 2024-12
Gilead Sciences USD 156.86B 16.13B 2026-06
Incyte USD 22.65B 3.92B 2026-06
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
Karyopharm Therapeutics USD 126M 9M 2026-03
Novartis USD 240.59B 67.17B 2026-06
Pfizer USD 138.44B 15.37B 2026-06
Roche Holding CHF 270B 3.66B 2026-06
Sarepta Therapeutics USD 1.9B 388M 2026-06
TG Therapeutics USD 8.41B 3.1B 2026-06
Ultragenyx Pharmaceutical USD 3.29B 1.23B 2026-06
Vertex Pharmaceuticals USD 126.07B 12.49B 2026-06
Xencor USD 1.19B 301M 2026-06